Asian Americans and cancer clinical trials: A mixed-methods approach to understanding awareness and experience

Debora A Paterniti, Moon S Chen, Christine Chiechi, Laurel A Beckett, Nora Horan, Corinne Turrell, Ligaya Smith, Claudia Morain, Lisa Montell, Jose Luis Gonzalez, Sharon Davis, Primo N Lara

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Cancer clinical trials have been based on low accrual rates. Barriers to recruitment of minority populations affect the generalizability and impact of trial findings for those populations. The authors undertook a mixed-methods approach to understanding levels of awareness and experiences with cancer clinical trials. A survey was administered to new cancer patients and their caretakers (family, close friends, or other social support) at outpatient oncology clinics. Field observations of the trial accrual process also were conducted by employing the grounded theory approach in qualitative methods. Comparison of survey results for Asian-American respondents and non-Asian respondents indicated that Asians were less likely to have heard the term "clinical trial" and were more likely to define a clinical trial as "an experiment" or "a test procedure in a clinic" than non-Asians. Asians were more likely to have employer-based insurance and to report understanding issues related to cost reimbursement. Asians were less likely to have been involved in or to know someone in a trial and reported less willingness than white respondents to consider trial participation. Qualitative observations suggested that Asians who presented for a potential trial were interested in the availability of a novel cancer therapy but were not eligible for available trials. Multiple strategies will be necessary to enhance awareness of and experience with accrual to cancer clinical trials for Asians, including richer understanding and increased involvement of Asians in cancer clinical trials and greater attention to the location and diversity of the Asian population in structuring study centers and evaluating trial results.

Original languageEnglish (US)
Pages (from-to)3015-3024
Number of pages10
JournalCancer
Volume104
Issue number12 SUPPL.
DOIs
StatePublished - Dec 15 2005

Fingerprint

Asian Americans
Clinical Trials
Neoplasms
Population
Ambulatory Care Facilities
Insurance
Social Support
Surveys and Questionnaires
Costs and Cost Analysis

Keywords

  • Accrual
  • Asian Americans
  • Clinical trials
  • Mixed-methods research

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Asian Americans and cancer clinical trials : A mixed-methods approach to understanding awareness and experience. / Paterniti, Debora A; Chen, Moon S; Chiechi, Christine; Beckett, Laurel A; Horan, Nora; Turrell, Corinne; Smith, Ligaya; Morain, Claudia; Montell, Lisa; Gonzalez, Jose Luis; Davis, Sharon; Lara, Primo N.

In: Cancer, Vol. 104, No. 12 SUPPL., 15.12.2005, p. 3015-3024.

Research output: Contribution to journalArticle

Paterniti, DA, Chen, MS, Chiechi, C, Beckett, LA, Horan, N, Turrell, C, Smith, L, Morain, C, Montell, L, Gonzalez, JL, Davis, S & Lara, PN 2005, 'Asian Americans and cancer clinical trials: A mixed-methods approach to understanding awareness and experience', Cancer, vol. 104, no. 12 SUPPL., pp. 3015-3024. https://doi.org/10.1002/cncr.21522
Paterniti, Debora A ; Chen, Moon S ; Chiechi, Christine ; Beckett, Laurel A ; Horan, Nora ; Turrell, Corinne ; Smith, Ligaya ; Morain, Claudia ; Montell, Lisa ; Gonzalez, Jose Luis ; Davis, Sharon ; Lara, Primo N. / Asian Americans and cancer clinical trials : A mixed-methods approach to understanding awareness and experience. In: Cancer. 2005 ; Vol. 104, No. 12 SUPPL. pp. 3015-3024.
@article{52bb46a7ada6404c80768d420dc80b6d,
title = "Asian Americans and cancer clinical trials: A mixed-methods approach to understanding awareness and experience",
abstract = "Cancer clinical trials have been based on low accrual rates. Barriers to recruitment of minority populations affect the generalizability and impact of trial findings for those populations. The authors undertook a mixed-methods approach to understanding levels of awareness and experiences with cancer clinical trials. A survey was administered to new cancer patients and their caretakers (family, close friends, or other social support) at outpatient oncology clinics. Field observations of the trial accrual process also were conducted by employing the grounded theory approach in qualitative methods. Comparison of survey results for Asian-American respondents and non-Asian respondents indicated that Asians were less likely to have heard the term {"}clinical trial{"} and were more likely to define a clinical trial as {"}an experiment{"} or {"}a test procedure in a clinic{"} than non-Asians. Asians were more likely to have employer-based insurance and to report understanding issues related to cost reimbursement. Asians were less likely to have been involved in or to know someone in a trial and reported less willingness than white respondents to consider trial participation. Qualitative observations suggested that Asians who presented for a potential trial were interested in the availability of a novel cancer therapy but were not eligible for available trials. Multiple strategies will be necessary to enhance awareness of and experience with accrual to cancer clinical trials for Asians, including richer understanding and increased involvement of Asians in cancer clinical trials and greater attention to the location and diversity of the Asian population in structuring study centers and evaluating trial results.",
keywords = "Accrual, Asian Americans, Clinical trials, Mixed-methods research",
author = "Paterniti, {Debora A} and Chen, {Moon S} and Christine Chiechi and Beckett, {Laurel A} and Nora Horan and Corinne Turrell and Ligaya Smith and Claudia Morain and Lisa Montell and Gonzalez, {Jose Luis} and Sharon Davis and Lara, {Primo N}",
year = "2005",
month = "12",
day = "15",
doi = "10.1002/cncr.21522",
language = "English (US)",
volume = "104",
pages = "3015--3024",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12 SUPPL.",

}

TY - JOUR

T1 - Asian Americans and cancer clinical trials

T2 - A mixed-methods approach to understanding awareness and experience

AU - Paterniti, Debora A

AU - Chen, Moon S

AU - Chiechi, Christine

AU - Beckett, Laurel A

AU - Horan, Nora

AU - Turrell, Corinne

AU - Smith, Ligaya

AU - Morain, Claudia

AU - Montell, Lisa

AU - Gonzalez, Jose Luis

AU - Davis, Sharon

AU - Lara, Primo N

PY - 2005/12/15

Y1 - 2005/12/15

N2 - Cancer clinical trials have been based on low accrual rates. Barriers to recruitment of minority populations affect the generalizability and impact of trial findings for those populations. The authors undertook a mixed-methods approach to understanding levels of awareness and experiences with cancer clinical trials. A survey was administered to new cancer patients and their caretakers (family, close friends, or other social support) at outpatient oncology clinics. Field observations of the trial accrual process also were conducted by employing the grounded theory approach in qualitative methods. Comparison of survey results for Asian-American respondents and non-Asian respondents indicated that Asians were less likely to have heard the term "clinical trial" and were more likely to define a clinical trial as "an experiment" or "a test procedure in a clinic" than non-Asians. Asians were more likely to have employer-based insurance and to report understanding issues related to cost reimbursement. Asians were less likely to have been involved in or to know someone in a trial and reported less willingness than white respondents to consider trial participation. Qualitative observations suggested that Asians who presented for a potential trial were interested in the availability of a novel cancer therapy but were not eligible for available trials. Multiple strategies will be necessary to enhance awareness of and experience with accrual to cancer clinical trials for Asians, including richer understanding and increased involvement of Asians in cancer clinical trials and greater attention to the location and diversity of the Asian population in structuring study centers and evaluating trial results.

AB - Cancer clinical trials have been based on low accrual rates. Barriers to recruitment of minority populations affect the generalizability and impact of trial findings for those populations. The authors undertook a mixed-methods approach to understanding levels of awareness and experiences with cancer clinical trials. A survey was administered to new cancer patients and their caretakers (family, close friends, or other social support) at outpatient oncology clinics. Field observations of the trial accrual process also were conducted by employing the grounded theory approach in qualitative methods. Comparison of survey results for Asian-American respondents and non-Asian respondents indicated that Asians were less likely to have heard the term "clinical trial" and were more likely to define a clinical trial as "an experiment" or "a test procedure in a clinic" than non-Asians. Asians were more likely to have employer-based insurance and to report understanding issues related to cost reimbursement. Asians were less likely to have been involved in or to know someone in a trial and reported less willingness than white respondents to consider trial participation. Qualitative observations suggested that Asians who presented for a potential trial were interested in the availability of a novel cancer therapy but were not eligible for available trials. Multiple strategies will be necessary to enhance awareness of and experience with accrual to cancer clinical trials for Asians, including richer understanding and increased involvement of Asians in cancer clinical trials and greater attention to the location and diversity of the Asian population in structuring study centers and evaluating trial results.

KW - Accrual

KW - Asian Americans

KW - Clinical trials

KW - Mixed-methods research

UR - http://www.scopus.com/inward/record.url?scp=29144478396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144478396&partnerID=8YFLogxK

U2 - 10.1002/cncr.21522

DO - 10.1002/cncr.21522

M3 - Article

C2 - 16247795

AN - SCOPUS:29144478396

VL - 104

SP - 3015

EP - 3024

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12 SUPPL.

ER -